Cargando…

Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds

BACKGROUND AND AIMS: Performance of two disposable devices for identifying subjects with low anti-SARS-CoV-2 protection was compared with that of automated enzyme-linked immunosorbent (ELISA) and chemiluminescent (CLIA) assay. MATERIALS AND METHODS: In July 2021, 123 healthcare workers (HCW), twice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padoan, Andrea, Cosma, Chiara, Galla, Luisa, Basso, Daniela, Plebani, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858771/ https://www.ncbi.nlm.nih.gov/pubmed/35202620 http://dx.doi.org/10.1016/j.cca.2022.02.014

Ejemplares similares

Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

A Comparative Serological Study of Toxoplasmosis in Pregnant Women by CLIA and ELISA Methods in Chalus City Iran
por: Elahian Firouz, Zahra, et al.
Publicado: (2014)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Comparative Evaluation and Measure of Accuracy of ELISAs, CLIAs, and ECLIAs for the Detection of HIV Infection among Blood Donors in China
por: Chang, Le, et al.
Publicado: (2020)

Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
por: Plebani, Mario, et al.
Publicado: (2020)

Evaluation of a Novel CLIA Monotest Assay for the Detection of Anti-Hepatitis E Virus-IgG and IgM: A Retrospective Comparison with a Line Blot and an ELISA
por: Dichtl, Karl, et al.
Publicado: (2021)

CLIA-certified next-generation sequencing analysis in the cloud
por: Zhang, Ying, et al.
Publicado: (2012)

Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection
por: Sekacheva, Marina, et al.
Publicado: (2023)

CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis
por: Rieken, Autumn, et al.
Publicado: (2021)

IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
por: Padoan, Andrea, et al.
Publicado: (2020)

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors
por: Bindoli, Sara, et al.
Publicado: (2023)

Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities
por: Klepser, Nicklas S., et al.
Publicado: (2021)

SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
por: Padoan, Andrea, et al.
Publicado: (2021)

Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers
por: Padoan, Andrea, et al.
Publicado: (2021)

Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
por: Padoan, Andrea, et al.
Publicado: (2019)

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies
por: Pi-Estopiñan, Franciscary, et al.
Publicado: (2022)

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein
por: Rodríguez, María Celeste, et al.
Publicado: (2022)

Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study
por: Basso, Daniela, et al.
Publicado: (2021)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology
por: Ortolan, Augusta, et al.
Publicado: (2021)

Ability of community pharmacists to independently perform CLIA-waived testing – A multistate legal review
por: Doucette, Joseph, et al.
Publicado: (2021)

Determination of vitamin D status in singleton and twin gestations using CLIA and LC-MS/MS
por: Zgliczyńska, Magdalena, et al.
Publicado: (2023)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

Disposable Device for Bacterial Vaginosis Detection
por: Avila-Huerta, Mariana D., et al.
Publicado: (2023)

Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
por: Villafañe, Luciana, et al.
Publicado: (2022)

Adversarial Thresholding Semi-Bandits
por: Bower, Craig Steven
Publicado: (2021)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
por: Bosa, Luca, et al.
Publicado: (2022)

The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave
por: Basso, Daniela, et al.
Publicado: (2022)

2356. Close correlation of RBD with Live Viral Neutralising Capacity Across Variants and Time Supports Use of RBD Thresholds to Predict Protective Host Immunity
por: Kenny, Grace, et al.
Publicado: (2023)

Elevated Humoral Immune Response to SARS-CoV-2 at High Altitudes Revealed by an Anti-RBD “In-House” ELISA
por: Tomas-Grau, Rodrigo Hernán, et al.
Publicado: (2021)

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees
por: Liu, Binjian, et al.
Publicado: (2022)

Buildout and integration of an automated high-throughput CLIA laboratory for SARS-CoV-2 testing on a large urban campus
por: Landaverde, Lena, et al.
Publicado: (2022)

Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment
por: Shihabuddin, Bashar S., et al.
Publicado: (2022)

Semi-high-throughput detection of Plasmodium falciparum and Plasmodium vivax oocysts in mosquitoes using bead-beating followed by circumsporozoite ELISA and quantitative PCR
por: Graumans, Wouter, et al.
Publicado: (2017)

A Semi-Quantitative Assay to Measure Glycosaminoglycan Degradation by the Urinary Microbiota
por: Nguyen, Vivian H., et al.
Publicado: (2022)

Quantitative anti-PA IgG ELISA; assessment and comparability with the anthrax toxin neutralization assay in goats
por: Ndumnego, Okechukwu C, et al.
Publicado: (2013)

Multiplexed Biosensing of Proteins and Virions with Disposable Plasmonic Assays
por: Wallace, Stephanie, et al.
Publicado: (2023)

Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots
por: Meyers, Eline, et al.
Publicado: (2022)

A Low-Cost SARS-CoV-2 rRBD ELISA to Detect Serostatus in Ecuadorian Population with COVID-19
por: Guevara, Ángel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a1qfrvtf49m5j0thc3sh76ltrj